Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 223.97M P/E - EPS this Y 17.60% Ern Qtrly Grth -
Income -87.98M Forward P/E -1.79 EPS next Y 57.10% 50D Avg Chg -11.00%
Sales - PEG 0.01 EPS past 5Y - 200D Avg Chg 4.00%
Dividend N/A Price/Book 0.93 EPS next 5Y -28.90% 52W High Chg -36.00%
Recommedations 3.00 Quick Ratio 9.91 Shares Outstanding 108.06M 52W Low Chg 95.00%
Insider Own 5.91% ROA -21.67% Shares Float 25.38M Beta 0.23
Inst Own 78.99% ROE -32.42% Shares Shorted/Prior 378.13K/232.75K Price 2.09
Gross Margin - Profit Margin - Avg. Volume 267,550 Target Price 3.90
Oper. Margin - Earnings Date - Volume 2,598,609 Change 5.56%
About LianBio

LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex blepharitis and meibomian gland disease; NBTXR3 for the treatment of head and neck squamous cell carcinoma, and solid tumor; Infigratinib for the treatment of second-line and first-line cholangiocarcinoma, and gastric cancers; BBP-398 for solid tumors; Omilancor and NX-13 for ulcerative colitis and Crohn's disease; LYR-210 for chronic rhinosinusitis; and Sisunatovir for respiratory syncytical virus. It has a partnership with Tarsus Pharmaceuticals, Inc. to develop and commercialize TP-03 for the treatment of Demodex blepharitis; and Nanobiotix S.A. to develop and commercialize NBTXR3, a radioenhancer designed to be injected directly into a malignant tumor prior to standard radiotherapy. The company was incorporated in 2019 and is headquartered in Princeton, New Jersey.

LIAN Chatroom

User Image Digital_Waffle_Pirate Posted - 1 week ago

@WallStArb $LIAN took 4 months

User Image Biotechace Posted - 1 week ago

$LIAN I didn't see getting hammered with an ADR fee coming.......Geez.

User Image WFC9000 Posted - 10/28/24

$LIAN Last major asset sold last week. Can't imagine we don't get an announcement of some kind by eoy highlighting next distribution.

User Image Dustman16 Posted - 2 months ago

$LIAN got that dividend payout a while back. Is this worth holding onto still?

User Image Biotechace Posted - 07/26/24

$LIAN appears good ole Perceptive Advisors sold all 57,000,000 plus of their shares on Q2. I guess they have no faith in the value of the pipeline they sold everyone on at $16.50 a share IPO. Thanks Perceptive!

User Image BorisYarmulnik Posted - 4 months ago

$LIAN

User Image Biotechace Posted - 4 months ago

$LIAN Grand Pharma purchased TP-03 rights for Greater China in March 2024? I did not know this. Was there a press release by anyone involved other than Grand Pharmaceutical? What were the terms of the purchase?

User Image BorisYarmulnik Posted - 6 months ago

$LIAN

User Image Biotechace Posted - 6 months ago

$LIAN see TARS. Crushed 2nd q revenue with TP-03. Someone will buy LIAN for China rights. More than twice as many potential patients in CHINA.

User Image Thecatsat Posted - 04/30/24

@Biotechace $LIAN Thanks for that. So how does one research the pipelines? Is there a favoured website? Thanks

User Image Thecatsat Posted - 04/29/24

$LIAN Is there any news on this? I can't find any. It's nice to see a bit of volume coming back in.

User Image insiderbuyingselling Posted - 7 months ago

$LIAN new insider selling: 1731 shares. http://insiderbuyingselling.com/?t=LIAN

User Image Forestluv Posted - 7 months ago

$LIAN Retail shareholders are fortunate to get a dividend equal to SP / liquidation value. Usually, retail gets screwed over during liquidation.

User Image Biotechace Posted - 03/29/24

$LIAN does anyone really believe TP-03 rights for Greater Asia and the rest of the assets are worth .32 per share. Isn't that the equivalent of approximately $37,000,000 total? I find this value comically low. What am I missing? LIAN paid $55,000,000 up front and they have completed all of the trials for approval. TARS (who they licensed TP-03 from) is skyrocketing on sales and projected future sales. Can someone enlighten me on why they think LIAN won't get significantly more for their pipeline than the current share price reflects?

User Image Biotechace Posted - 03/28/24

$LIAN earnings Monday before the market opens. Maybe we will start to get some clues on the value of the pipeline and the plan going forward. I still contend this is undervalued.

User Image Bbboston Posted - 03/25/24

$LIAN A question for all you experts out there!! How is a company have so many assets (and potentially huge assets in some cases) with such companies as Bridgebio (multiple indications) Tarsus (2 indications) Nanobiotix (believe they got bought out by Pfz) Landos (for UC) Libra All of that and still a mere 30/35 mil MC? I am no expert on this matter but this seems awfully cheap!!! I mean look at Landos. That alone got bought out today for $137mil And LIAN holds the rights for China. What am I messing here? Many thanks in advance.

User Image Tika1 Posted - 03/25/24

$IMAB What is possibility this company sells all IPs and US right and distribute cash just like $LIAN ? In that case we might get $4-5.

User Image Biotechace Posted - 8 months ago

$LIAN LIANY

User Image Dustman16 Posted - 8 months ago

$LIAN wow, a lot of bots or ppl that just have no clue what they’re talking about.

User Image Dexu Posted - 8 months ago

$LIAN pre mkt 0.31 looks like the end is closer

User Image muni12 Posted - 8 months ago

$LIAN filing says delisted should be today.. why’s it still listed 🤨

User Image muni12 Posted - 8 months ago

$LIAN voluntary delist but no delist date..

User Image History101 Posted - 8 months ago

$LIAN 542 watching 3/17/2024

User Image teambullish Posted - 8 months ago

In my approach, treating Mondays as trend days and emphasizing thorough analysis helps me ease into the week, rather than diving in headfirst and risking a poor start. This allows me to gradually acclimate to the market's rhythm each week, setting a deliberate pace that avoids the outcomes of hasty decisions. By consistently reinforcing disciplined habits and prioritizing in-depth analysis, I can identify high-quality setups that offer substantial value, enabling me to exploit market movements more effectively and efficiently. This approach not only creates a stable foundation for the week but also enhances my ability to navigate trades with precision, leveraging a more comprehensive understanding of price action, supply and demand to generate higher probability outcomes. Catch you in the morning. $VERB $LIAN $SOUN $GERN $HOLO

User Image hridbai Posted - 8 months ago

$LIAN Our analyst predicted the PUMP on $ATCH, allowing our FREE trial members to lock in 40% in profits!

User Image tradingtwenty Posted - 8 months ago

Top 5 stocks by highest volume percent change (today vs 3-month average): $VERB 52394.08% 🔥 $JTAI 14801.14% $BTTX 6367.88% $LIAN 4163.52% $CDLX 2331.48% Link: https://tradingtwenty.com/dashboard/trending/past

User Image tradingtwenty Posted - 8 months ago

Top 5 stock gainers today that have trended in the past 24 hours: $VERB 215.86% 🔥 $GERN 92.00% $LIAN 83.05% $CDLX 77.15% $JTAI 59.72% Link: https://tradingtwenty.com/dashboard/trending/past

User Image CubensisMoya Posted - 8 months ago

$LIAN got in premarket .268, crazy volume today

User Image AZona Posted - 8 months ago

Top Gainers 3/15 🔥 $LIAN $VERB $GERN $CDLX $CJET 🫶 Congrats Bulls! 🤑

User Image Stgcsbren Posted - 8 months ago

$LIAN dip and rip

Analyst Ratings
B of A Securities Underperform Jan 3, 24
Jefferies Hold Dec 22, 23
Raymond James Outperform Oct 25, 23
Raymond James Outperform Oct 14, 22
Goldman Sachs Neutral Nov 26, 21
Jefferies Buy Nov 26, 21
Raymond James Outperform Nov 24, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
PERCEPTIVE ADVISORS LLC Director Director Aug 18 Buy 2.40 998,240 2,395,776 3,728,491 08/22/22
PERCEPTIVE ADVISORS LLC Director Director May 26 Buy 3.13 69,000 215,970 2,730,251 05/27/22
PERCEPTIVE ADVISORS LLC Director Director May 23 Buy 2.53 171,251 433,265 2,661,251 05/25/22
PERCEPTIVE ADVISORS LLC Director Director Nov 01 Buy 14.5 220,000 3,190,000 7,253,885 11/03/21